Cargando…

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. METHODS: We evaluated BAL cell cytokine profiles and BAL di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schupp, Jonas Christian, Binder, Harald, Jäger, Benedikt, Cillis, Giuseppe, Zissel, Gernot, Müller-Quernheim, Joachim, Prasse, Antje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295887/ https://www.ncbi.nlm.nih.gov/pubmed/25590613 http://dx.doi.org/10.1371/journal.pone.0116775

Ejemplares similares

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
por: Stahl, Mirjam, et al.
Publicado: (2013)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
por: Pechkovsky, Dmitri V, et al.
Publicado: (2005)

The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
por: Jäger, Benedikt, et al.
Publicado: (2021)

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations
por: Kishore, Amit, et al.
Publicado: (2016)

Immune response to Propionibacterium acnes in patients with sarcoidosis – in vivo and in vitro
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

CD71(−) Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease
por: Puxeddu, Ermanno, et al.
Publicado: (2019)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2017)

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2018)

Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis
por: Landi, Claudia, et al.
Publicado: (2011)

Airway basal cells show a dedifferentiated KRT17(high)Phenotype and promote fibrosis in idiopathic pulmonary fibrosis
por: Jaeger, Benedikt, et al.
Publicado: (2022)

Bronchoalveolar Lavage Fluid Reflects a T(H)1-CD21(low) B-Cell Interaction in CVID-Related Interstitial Lung Disease
por: Friedmann, David, et al.
Publicado: (2021)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kishaba, Tomoo
Publicado: (2019)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2013)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2018)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2022)

Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis—Part B
por: Caliskan, Canay, et al.
Publicado: (2020)

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
por: Plönes, Till, et al.
Publicado: (2012)

CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential
por: Ploenes, Till, et al.
Publicado: (2013)

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP
por: Scherr, Benedikt F., et al.
Publicado: (2023)

Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
por: Höhne, Kerstin, et al.
Publicado: (2012)

Approach to acute exacerbation of idiopathic pulmonary fibrosis
por: Bhatti, Hammad, et al.
Publicado: (2013)

Acute exacerbations in patients with idiopathic pulmonary fibrosis
por: Kim, Dong Soon
Publicado: (2013)

Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)

Acute Exacerbations in Patients With Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2018)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
por: Oda, Keishi, et al.
Publicado: (2014)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Weng, Dong, et al.
Publicado: (2019)

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
por: Kakugawa, Tomoyuki, et al.
Publicado: (2016)

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020)

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
por: Seeliger, Benjamin, et al.
Publicado: (2022)

A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
por: Prasse, Antje, et al.
Publicado: (2019)

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial
por: Frye, Björn C., et al.
Publicado: (2020)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2020)

Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Donahoe, Michael, et al.
Publicado: (2015)

Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Cao, Mengshu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ct0fqrv20uauka6c5cfn8dlv04